Hallucinogens: LSD, Peyote, Psilocybin, PCP & Psychedelics
Understanding hallucinogens: Effects, risks, and what you need to know about psychedelic drugs.

Understanding Hallucinogens and Psychedelics
Hallucinogens, commonly referred to as psychedelics, are a diverse group of drugs that fundamentally alter a person’s perception of reality. These substances profoundly affect thoughts, emotions, and sensory experiences, creating what users often call “trips.” Nearly all hallucinogens remain illegal in most jurisdictions, and researchers maintain that no amount of use is considered safe.
The term “psychedelic” derives from Greek, meaning “mind manifesting,” accurately describing how these drugs produce intense, altered states of consciousness. Unlike many recreational substances, hallucinogens do not typically create the same pattern of physical dependence as alcohol or opioids, yet they carry significant psychological risks and potential for adverse effects.
How Hallucinogens Work in the Brain
Hallucinogens operate through different neurochemical mechanisms depending on their specific structure and composition. The primary mechanism involves disrupting communication between chemical networks throughout the brain.
Serotonin Disruption: Many classic hallucinogens, including LSD and psilocybin, work by interfering with serotonin, a crucial neurotransmitter that regulates mood, perception, appetite, sleep patterns, and cognitive functions. By modulating serotonin receptors, these substances fundamentally alter how the brain processes sensory information and emotional responses.
Glutamate Interference: Other hallucinogenic drugs, such as PCP, interfere with glutamate, another important neurotransmitter responsible for memory formation, learning, and neural communication. This disruption creates profound dissociative experiences.
The effects of hallucinogens extend beyond simple hallucinations to create comprehensive alterations in consciousness, affecting physical sensations, perception, cognition, and emotional states simultaneously.
Common Types of Hallucinogens
Lysergic Acid Diethylamide (LSD)
LSD stands as one of the most potent and extensively studied hallucinogens. This powerful serotonergic agent causes users to lose touch with reality, often resulting in mystical experiences and sensory blending. Many users report synesthesia—a phenomenon where senses cross, such as “smelling” sounds or “hearing” colors.
The effects of LSD typically last between nine to twelve hours, with onset occurring 30 minutes to 2 hours after ingestion. Users may experience dilated pupils, increased heart rate, elevated blood pressure, and changes in body temperature. While LSD is not considered addictive in the traditional sense—it does not produce compulsive drug-seeking behavior—tolerance develops with repeated use, requiring higher doses to achieve similar effects.
Peyote and Mescaline
Peyote, derived from the Lophophora williamsii cactus, contains the psychoactive alkaloid mescaline. Traditionally used in indigenous religious ceremonies, peyote produces hallucinogenic effects at doses of approximately 0.3 to 0.5 grams, with effects lasting around 12 hours.
The extremely bitter taste of peyote extract leads many users to prepare it as a tea by boiling the cacti for several hours. Modern versions of this substance can also be synthesized chemically in laboratories. Users typically experience visual distortions, altered time perception, and emotional intensity.
Psilocybin (Magic Mushrooms)
Psilocybin, the active compound in certain species of mushrooms, represents another significant serotonergic hallucinogen. Contemporary research increasingly focuses on psilocybin’s potential therapeutic applications for treating depression, PTSD, and anxiety disorders.
When consumed, psilocybin produces effects similar to LSD, including altered visual perception, emotional openness, and shifts in consciousness. The duration and intensity depend on dosage, with effects typically lasting 4 to 6 hours.
Phencyclidine (PCP)
PCP represents a distinctly different category of hallucinogen, operating through glutamate receptor antagonism rather than serotonin modulation. Originally developed in the 1950s as a general anesthetic, PCP was abandoned for medical use in 1965 due to severe and unpredictable side effects.
This dissociative drug creates profound out-of-body sensations and detachment from reality. The comedown from PCP produces numbing effects that frequently trigger agitation and irrational behavior. At high doses, PCP can cause seizures, coma, and death.
Effects of Hallucinogens
Positive and Negative Experiences
Users describe hallucinogenic experiences as either “good trips” or “bad trips.” Good trips involve positive, meaningful experiences with visual beauty, emotional insight, and spiritual awakening. Bad trips encompass frightening, distressing experiences including paranoia, panic, and fear.
During bad trips, individuals may harm themselves, experience intense anxiety, or lose the ability to distinguish reality from hallucination. These negative experiences frequently prompt emergency room visits and require immediate medical intervention.
Short-Term Effects by Drug Type
| Drug | Primary Effects | Duration | Key Characteristics ||——|—————–|———-|———————|| LSD | Sensory blending, mystical visions, euphoria or anxiety | 9-12 hours | Synesthesia, pupil dilation, increased vital signs || Peyote | Visual distortions, emotional intensity, time distortion | ~12 hours | Extreme bitterness, spiritual significance || Psilocybin | Altered perception, emotional openness, introspection | 4-6 hours | Potential therapeutic applications, variable effects || PCP | Dissociation, out-of-body sensation, numbness | Variable | High danger, unpredictability, violent behavior risk |
Low-Dose Effects
At lower doses, hallucinogens produce subtle perceptual shifts, mild visual distortions, and enhanced emotional sensitivity. Users maintain relatively good contact with reality and retain awareness of the drug’s influence.
High-Dose Effects
At higher doses—particularly with DMT, LSD, or salvinorin-A—hallucinations become intense and all-encompassing. Users experience complete transformation of subjective reality, often describing the sensation of entering entirely different worlds or dimensions. These experiences transcend simple perception and involve fundamental restructuring of thought patterns and reality processing.
Health Risks and Adverse Effects
Psychological Risks
Hallucinogens carry significant psychological dangers. Bad trips can trigger severe anxiety, panic attacks, paranoia, and persistent fear even after the drug’s effects wear off. Some individuals experience lasting psychological distress or exacerbation of underlying mental health conditions.
For individuals with personal or family history of psychosis or schizophrenia, hallucinogens pose heightened risks of triggering or worsening these serious mental health conditions.
Physical Risks Associated with Specific Drugs
PCP-Related Dangers
PCP presents particularly severe risks. At low-to-moderate doses, users experience increased breathing rate, elevated blood pressure, and accelerated pulse. Higher doses can produce:
- Seizures and convulsions
- Coma and loss of consciousness
- Violent or suicidal behavior
- Accidental injury due to impaired judgment
- Death from overdose or accidents
PCP users frequently require emergency medical care. The drug’s sedative properties create dangerous interactions with central nervous system depressants like alcohol, potentially leading to respiratory depression and death.
Other Drug-Specific Risks
Drug interactions pose serious hazards. For instance, mixing psilocybin with monoamine oxidase inhibitors (MAOIs) and stimulants can trigger hypertensive crises—dangerous spikes in blood pressure requiring immediate emergency treatment.
Common adverse effects across hallucinogens include anxiety, jaw clenching, muscle tension, reduced appetite, nausea, dizziness, and excessive sweating.
Long-Term Consequences
While hallucinogens are not considered addictive in the traditional sense, long-term continued use can lead to psychological dependence. Tolerance develops, requiring increasingly higher doses. Some individuals experience flashbacks or hallucinogen persisting perception disorder (HPPD), where visual disturbances recur without taking the drug again.
Treatment for Hallucinogen Intoxication
When individuals seek treatment for hallucinogen overdose or severe bad trips, providers employ supportive care strategies. Treatment typically involves:
- Placing the patient in a quiet, calm environment with minimal sensory stimulation
- Providing reassurance and emotional support
- Monitoring vital signs for any dangerous physiological changes
- Administering benzodiazepines (such as Xanax) to manage extreme agitation, anxiety, or seizures
- Ensuring patient safety to prevent self-harm
Medical teams focus on harm reduction and allowing the drug’s effects to naturally diminish while maintaining a safe, supportive environment.
Legal Status and Current Research
Nearly all hallucinogens remain classified as Schedule I controlled substances in the United States and are similarly prohibited in most countries worldwide. This legal classification reflects current policy, though emerging research suggests potential therapeutic benefits that may warrant reconsideration of these substances’ regulatory status.
Contemporary scientific investigation increasingly explores psychedelic-assisted therapy for treating depression, PTSD, anxiety disorders, and other neuropsychiatric conditions. Major medical institutions, including Cleveland Clinic, have initiated rigorous clinical studies examining psilocybin’s safety and efficacy for mental health treatment.
Frequently Asked Questions
Q: Are hallucinogens addictive?
A: Most classic hallucinogens like LSD and psilocybin are not considered addictive because they do not produce compulsive drug-seeking behavior. However, psychological dependence can develop with frequent use, and tolerance builds rapidly, requiring higher doses for similar effects.
Q: What is the difference between a good trip and a bad trip?
A: A good trip involves positive, meaningful experiences with visual beauty and emotional insight. A bad trip encompasses frightening, distressing experiences including paranoia, panic, and fear. Bad trips can result in self-harm and require medical intervention.
Q: How long do hallucinogenic effects last?
A: Duration varies by substance. LSD effects last 9-12 hours, peyote approximately 12 hours, psilocybin 4-6 hours, and PCP effects are more variable. Onset times also differ significantly among these drugs.
Q: Can hallucinogens cause permanent damage?
A: While most hallucinogens do not cause permanent neurological damage, they can trigger lasting psychological effects. Some individuals experience hallucinogen persisting perception disorder (HPPD), where visual disturbances recur without using the drug again. Additionally, they can exacerbate or trigger underlying mental health conditions.
Q: Is there any therapeutic potential for hallucinogens?
A: Contemporary research suggests potential therapeutic applications of psilocybin and LSD for treating depression, PTSD, anxiety disorders, and other neuropsychiatric conditions. Clinical trials are underway at major medical centers, though more research is needed before clinical approval.
Q: What should someone do if experiencing a bad trip?
A: Move to a quiet, calm environment with minimal sensory stimulation. Seek professional medical help if experiencing severe distress, self-harm impulses, or dangerous behavior. Medical providers can offer supportive care and medication to manage extreme agitation or anxiety.
Seeking Help and Support
If you have questions about hallucinogen use or believe you may be experiencing substance use disorder, reaching out to a healthcare provider is essential. Medical professionals can provide confidential support, assess your specific situation, and connect you with appropriate treatment resources. You don’t have to navigate substance use concerns alone—professional help and support systems exist to guide your recovery and wellness journey.
References
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Properties — National Center for Biotechnology Information. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10716812/
- Hallucinogens: LSD, Peyote, Psilocybin, PCP & Other Psychedelic Drugs — Cleveland Clinic. 2023. https://my.clevelandclinic.org/health/articles/6734-hallucinogens-lsd-peyote-psilocybin-and-pcp
- Clinicians Emphasize Harm Reduction When Counseling Patients About the Use of Psychedelics — Cleveland Clinic Consult QD. 2024. https://consultqd.clevelandclinic.org/clinicians-emphasize-harm-reduction-when-counseling-patients-about-the-use-of-psychedelics
- Psychedelic-Assisted Therapy: An Overview for the Internist — Cleveland Clinic Journal of Medicine. 2024. https://www.ccjm.org/content/92/3/171
- Hypertensive Crisis Linked to Psilocybin Mushroom Use in Patient Taking MAOI and Amphetamine — Cleveland Clinic Consult QD. 2024. https://consultqd.clevelandclinic.org/hypertensive-crisis-linked-to-psilocybin-mushroom-use-in-patient-taking-maoi-and-amphetamine
- American Psychiatrists Reveal Changing Attitudes About the Therapeutic Use of Classic Hallucinogens — Cleveland Clinic Consult QD. 2024. https://consultqd.clevelandclinic.org/american-psychiatrists-reveal-changing-attitudes-about-the-therapeutic-use-of-classic-hallucinogens
Read full bio of medha deb














